Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery

Oct.12.2024
Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
A new Innokin Trine e-cigarette with replaceable battery has hit shelves in Europe, meeting upcoming EU regulations.

Recently, 2Firsts noticed a new type of replaceable battery e-cigarette called the Innokin Trine being showcased at a tobacco exhibition in Dortmund. The product, launched by e-cigarette brand Innokin, is now available on e-cigarette retail websites in regions such as the UK and Germany. With its design allowing for replaceable batteries, the product complies with the new regulations set to be implemented by the EU Battery Directive in 2026.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Innokin Trine displayed at the tobacco exhibition in Dortmund by Innokin|Image source: 2Firsts


At the recent Dortmund tobacco exhibition, several exhibitors showcased e-cigarette products with replaceable batteries, including disposable, pod-based, and open-system devices, in response to the EU's Battery Directive. According to the directive, by 2026, batteries in portable devices (such as disposable e-cigarettes) must be easily removable and replaceable by the user.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image Source | Innokin Official Website


The newly released Innokin Trine, an open system product from Innokin, complies with the upcoming new regulations in the European Union market.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin official website


In addition, the main feature of Trine is its "three-in-one" structure: atomizer, detachable and rechargeable battery, control panel. At the same time, the detachable and rechargeable battery enhances the convenience and durability of the device.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin brand official website


Specifically, the main product features of the Innokin Trine include:


E-liquid capacity: 2ml Nicotine concentration: Supports a variety of nicotine levels in e-liquid Battery capacity: 1000mAh removable battery Charging method: Supports Type-C fast charging.


Trine Power Hub charger charges


Backup batteries can also be purchased separately.


Power Mode: Provides a power output of 6-25W.


Function: - Suction activation


Support mouth to lung (MTL) or limit direct lung (RDL) inhale mode.


Compatible with a variety of e-liquid flavors.


Charging indicator light


The screen displays operational parameters such as output power and battery level.


Currently, the Innokin Trine has been listed on the official website of the Innokin e-cigarette brand and major distributor websites in Europe, with a selling price of approximately 19.95 euros.


In addition to the Innokin brand, other brands such as GOLISI and NEXIONE have also introduced similar products with replaceable batteries. 2Firsts will continue to monitor the latest products and market trends in replaceable battery e-cigarette products, providing the public with accurate and authoritative industry information.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canada Health Minister Says She Is Not Considering Looser Nicotine Pouch Retail Rules as PMI-Linked Group Pushes for Wider Access
Canadian Health Minister Marjorie Michel says she is not considering loosening retail restrictions on nicotine pouches. Canada regulates pouches containing 4 mg or less of nicotine per unit as non-prescription nicotine replacement therapy and requires newer NRT formats such as pouches to be sold from behind pharmacy counters. Meanwhile, Unsmoke Canada, linked to Philip Morris International's Canadian business, is pushing to allow pouches in convenience stores and other general retail outlets. Health Canada also acknowledges continued unauthorized sales, while recent research shows rising pouch use among Canadian youth aged 16 to 19.
Sep.24
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives